Atorvastatin

Atorvastatin is a prescription medication used to lower cholesterol and reduce the risk of heart disease and stroke. Studies have demonstrated its effectiveness in reducing cardiovascular events, particularly when administered before percutaneous coronary intervention. Additionally, atorvastatin has been shown to improve vascular endothelial function in hypertension by promoting the degradation of ATP5A through WWP2-mediated ubiquitination. However, it can also cause side effects such as gynecomastia and may impact erectile function.

Atorvastatin is often used in combination with other medications like ezetimibe for more effective cholesterol management. When coadministered, the combination has been found to significantly lower LDL cholesterol levels compared to atorvastatin alone. The medication can also have side effects, including renal impairment, which is supported by cohort studies with moderate evidence.

The strongest connections associated with atorvastatin include its impact on vascular health and potential side effects such as gynecomastia and erectile dysfunction. While the evidence for these associations is robust, further research may be needed to fully understand the long-term implications of atorvastatin use.

Sources

• Clinical pharmacokinetics of atorvastatin. (PMID:14531725)
• Atorvastatin before percutaneous coronary intervention: A systematic review and meta-analysis. (PMID:38165842)
• Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. (PMID:12719279)
• Atorvastatin-Associated Gynecomastia. (PMID:33472378)
• Impact of atorvastatin on erectile dysfunction: A meta-analysis and systematic review. (PMID:35224753)
• Atorvastatin rescues vascular endothelial injury in hypertension by WWP2-mediated ubiquitination and degradation of ATP5A. (PMID:37557013)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._